Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
Stopped The decision to permanently close PBTC-053 was made following communication from the NCI that the PBTC grant will not be extended beyond March 31, 2026.
Conditions
- Medulloblastoma, Childhood
- Medulloblastoma Recurrent
- Medulloblastoma
Interventions
Sponsor
Pediatric Brain Tumor Consortium
Collaborators
- [object Object]
- [object Object]
- [object Object]